Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Faeth Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −8 vs. Q2 2022
- Shares held
- 2.88M
- −213.5K (−6.9%) vs. Q2 2022
- Total value
- $4.47M
- −$2.56M (−36.4%) vs. Q2 2022
- New holders
- 4
- 6 more added
- Sold out
- 12
- 13 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $68.0M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.2K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.43M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 120 | $0 | 0.00% | +59+96.7% | Added |
| Harbour Investments, Inc. | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 77 | $0 | 0.00% | +77 | New |
| China Universal Asset Management Co., Ltd. | 288 | $0 | 0.00% | +288 | New |
| BNP Paribas Arbitrage, SA | 603 | $935 | 0.00% | +603 | New |
| Citigroup Inc | 361 | $1.00K | 0.00% | −311−46.3% | Reduced |
| JPMorgan Chase & Co | 1,713 | $3.00K | 0.00% | +412+31.7% | Added |
| Banque Cantonale Vaudoise | 3,900 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,837 | $7.00K | 0.00% | +455+10.4% | Added |
| Goldman Sachs Group Inc | 10,446 | $16.0K | 0.00% | −610−5.5% | Reduced |
| Dimensional Fund Advisors LP | 11,570 | $18.0K | 0.00% | +11,570 | New |
| UBS Group AG | 13,114 | $20.0K | 0.00% | −349−2.6% | Reduced |
| Morgan Stanley | 13,569 | $21.0K | 0.00% | −12,606−48.2% | Reduced |
| Qube Research & Technologies Ltd | 16,711 | $26.0K | 0.00% | −2,042−10.9% | Reduced |
| Raymond James & Associates | 19,000 | $29.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 25,774 | $40.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 26,049 | $40.0K | 0.00% | +10,507+67.6% | Added |
| Two Sigma Investments, LP | 35,776 | $55.0K | 0.00% | −3,000−7.7% | Reduced |
| Bank of America Corp | 36,906 | $57.0K | 0.00% | +20,035+118.8% | Added |
| Two Sigma Advisers, LP | 37,900 | $59.0K | 0.00% | −3,200−7.8% | Reduced |
| HighTower Advisors, LLC | 50,229 | $78.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 79,081 | $123.0K | 0.00% | −54,624−40.9% | Reduced |
| Ergoteles LLC | 89,967 | $139.0K | 0.00% | −3,631−3.9% | Reduced |
| Geode Capital Management, LLC | 91,895 | $142.0K | 0.00% | 00.0% | Unchanged |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 100,000 | $155.0K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 162,900 | $252.0K | 0.01% | +125,000+329.8% | Added |
| BlackRock Inc. | 173,950 | $270.0K | 0.00% | −4,944−2.8% | Reduced |
| Renaissance Technologies LLC | 205,800 | $319.0K | 0.00% | −41,200−16.7% | Reduced |
| Newtyn Management, LLC | 415,000 | $643.0K | 0.14% | 00.0% | Unchanged |
| Vanguard Group Inc | 573,456 | $889.0K | 0.00% | −96,116−14.4% | Reduced |
| Ra Capital Management, L.P. | 683,529 | $1.06M | 0.02% | −40,020−5.5% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −59,380−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −19,934−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,917−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −12,901−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,223−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,674−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −196−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −199−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −156−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| BFT Financial Group, LLC | – | – | – | – | Not filed |